| Serial Number | 87901794 |
| Word Mark | ADVENT ADVANCES IN TYPE 2 IMMUNE DISEASES |
| Filing Date | Tuesday, May 1, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, February 5, 2019 |
| Registration Number | 5668962 |
| Registration Date | Tuesday, February 5, 2019 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, November 20, 2018 |
| Goods and Services | Educational services, namely, arranging and conducting classes, seminars, conferences, and workshops for patients with immune system related diseases and disorders, namely, asthma, atopic dermatitis, and nasal polyposis, in the fields of immunology and inflammatory diseases |
| Description of Mark | The mark consists of the stylized wording "ADVENT" below two slightly offset chevrons facing the opposite direction. The letters "AD" appear in a dark teal, whereas the letters "VENT" appear in a light teal. The left-pointing chevron is shaded light gray to dark gray from left to right, and the right-pointing chevron is shaded dark teal to light teal from left to right. A dark gray shadow between the two chevrons gives the illusion of depth. The stylized wording "ADVANCES IN TYPE 2 IMMUNE DISEASES" appears in light gray below the wording "ADVENT". |
| Pseudo Mark | ADVENT ADVANCES IN TYPE TWO IMMUNE DISEASES |
| Indication of Colors claimed | The color(s) light teal, dark teal, light gray, and dark gray is/are claimed as a feature of the mark. |
| Disclaimer with Predetermined Text | "ADVANCES IN TYPE 2 IMMUNE DISEASES" |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 9, 2018 |
| Primary Code | 041 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Sanofi Biotechnology |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Paris 75008 FR |
| Party Name | Sanofi Biotechnology |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Paris 75008 FR |
| Party Name | Sanofi Biotechnology |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Paris 75008 FR |
| Event Date | Event Description |
| Monday, February 5, 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Wednesday, January 8, 2020 | REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED |
| Tuesday, December 10, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, February 5, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, November 20, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 20, 2018 | PUBLISHED FOR OPPOSITION |
| Wednesday, October 31, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, October 12, 2018 | ELECTRONIC RECORD REVIEW COMPLETE |
| Friday, October 12, 2018 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Monday, October 1, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, September 12, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, September 12, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, September 11, 2018 | ASSIGNED TO LIE |
| Wednesday, August 29, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, August 2, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, August 2, 2018 | NON-FINAL ACTION E-MAILED |
| Thursday, August 2, 2018 | NON-FINAL ACTION WRITTEN |
| Wednesday, July 25, 2018 | ASSIGNED TO EXAMINER |
| Thursday, May 10, 2018 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, May 9, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, May 4, 2018 | NEW APPLICATION ENTERED |